Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs.

iScience · 2026 · PMC12803865 · PMID 41541692

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

No difference was observed in the ferroptosis marker ACSL5 ( Figure S5 G); while evaluating autophagy markers (LAMP2 and p62), only LAMP2 showed a trend toward increased expression in treated (DDP+MET/IF) compared with control (untreated) samples ( Figure S5 I; Table S5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.